News
1h
News-Medical.Net on MSNDynamic BH3 profiling offers personalized lung cancer therapiesEighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.
Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...
NX-5948 assigned the nonproprietary name “bexobrutideg”U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström ...
Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.
NX-5948 assigned the nonproprietary name "bexobrutideg"U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemiaAchieved $7M in milestones and a $15M ...
Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharyngeal epithelium. Due to its concealed location and nonspecific ...
During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...
This month's cover highlights the article Natural variations of adolescent neurogenesis and anxiety predict the hierarchical status of adult inbred mice by Nicolas Toni, Thomas Larrieu and colleagues.
IL-37 expression has been identified in diverse tissues, including lymph nodes, thymus, lung, intestine, uterus, and various immune cell types (NK cells, activated B cells, monocytes), as well as ...
Immunizing mice with an edited Lyme disease-causing bacterial protein effectively protected them against the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results